Physician

Chad A Brown, MD

According to 2025 Medicare claims, Chad Brown, MD (NPI: 1598766933) practices dermatology in the Elizabethtown, KY market, with the plurality of this provider's patient population coming from Hardin, KY. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1477922672; TIN: 391351587) and primary practice location at 42701-9162.

Brown's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,472 traditional Medicare patients, billed 6,904 HCPCS/CPT codes, and received $266,299 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,322 prescription claims across 551 beneficiaries totaling $1,685,033 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 114 records totaling $2,314. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $621,796 to $1,685,033. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$144K$288K2015 Medicare payment: $269,830 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $246,682 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $274,566 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $268,211 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $258,559 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $251,077 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $288,476 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $271,657 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $272,509 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $266,299 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,6117,540$269,830
20161,5787,355$246,682
20171,6058,588$274,566
20181,6428,192$268,211
20191,6327,396$258,559
20201,5867,237$251,077
20211,6028,050$288,476
20221,5017,767$271,657
20231,5217,672$272,509
20241,4726,904$266,299

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$912K$1.8M2015 Drug cost: $621,796 (USD; Tot_Drug_Cst)2016 Drug cost: $728,284 (USD; Tot_Drug_Cst)2017 Drug cost: $749,012 (USD; Tot_Drug_Cst)2018 Drug cost: $676,641 (USD; Tot_Drug_Cst)2019 Drug cost: $608,690 (USD; Tot_Drug_Cst)2020 Drug cost: $766,965 (USD; Tot_Drug_Cst)2021 Drug cost: $836,925 (USD; Tot_Drug_Cst)2022 Drug cost: $1,124,544 (USD; Tot_Drug_Cst)2023 Drug cost: $1,824,293 (USD; Tot_Drug_Cst)2024 Drug cost: $1,685,033 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154861,183$621,796
20164641,236$728,284
20174151,014$749,012
2018414949$676,641
2019404881$608,690
2020437952$766,965
20214351,042$836,925
2022420984$1,124,544
20234761,150$1,824,293
20245511,322$1,685,033

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths261294$73
11102Biopsy of related skin growth, first growth345391$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0701,371$57
17000Destruction of precancer skin growth, 1 growth625785$37
17003Destruction of precancer skin growth, 2-14 growths4732,295$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa241,904$478,758
Cosentyx Sensoready (2 Pens)Secukinumab32896$237,139
Humira(Cf) PenAdalimumab16448$217,893
OtezlaApremilast27810$131,235
Dupixent SyringeDupilumab12348$44,852

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.114$2,314UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Chad A. Brown, MD?

Tedicare shows public-source Medicare data for Chad A. Brown, MD (NPI 1598766933), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chad A. Brown, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chad A. Brown, MD?

Chad A. Brown, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1477922672) in the available physician profile data.

Does Chad A. Brown, MD have Open Payments data?

Chad A. Brown, MD has 114 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.